PHAXIAM Therapeutics

PHAXIAM Therapeutics is a biopharmaceutical company specializing in innovative bacteriophage-based therapies to combat resistant bacterial infections

Biotech & Life Sciences

Sector

Seed

Stage

Biopharmaceutical

Model

01Company Overview

PHAXIAM Therapeutics is a biopharmaceutical company specializing in innovative bacteriophage-based therapies to combat resistant bacterial infections. It was formed from the merger of ERYTECH and PHERECYDES in June 2023 and aimed to become a global leader in phage therapy.

02Backed By1 investor

GCGO CAPITAL→

03Similar Companies

Is this your company? Claim your profile